Estrogen receptor status low status in breast cancer: clinicopathological factors and prognostic value
Menopausal Review · 2026 · 25 (1) · 24-29
DOI: 10.5114/pm.2026.161538 ↗Kurz gefasst
Fachartikel in der Zeitschrift Menopausal Review, 2026. Verfasst von Joanna Huszno und 6 weiteren Autor:innen. Beteiligte Einrichtung: Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
- Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
- Tumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Zitieren
APA
Huszno, J., Kołosza, Z., Stobiecka, E., Ponikiewska, D., Szcześniak, B., Simek, J., & Chmielik, E. (2026). Estrogen receptor status low status in breast cancer: clinicopathological factors and prognostic value. Menopausal Review, 25(1), 24-29. https://doi.org/10.5114/pm.2026.161538
Vancouver
Huszno J, Kołosza Z, Stobiecka E, Ponikiewska D, Szcześniak B, Simek J, et al. Estrogen receptor status low status in breast cancer: clinicopathological factors and prognostic value. Menopausal Review. 2026;25(1):24-29. doi:10.5114/pm.2026.161538
BibTeX
@article{Huszno2026,
author = {Huszno, Joanna and Kołosza, Zofia and Stobiecka, Ewa and Ponikiewska, Dorota and Szcześniak, Bogna and Simek, Jakub and Chmielik, Ewa},
title = {Estrogen receptor status low status in breast cancer: clinicopathological factors and prognostic value},
journal = {Menopausal Review},
year = {2026},
volume = {25},
number = {1},
pages = {24--29},
doi = {10.5114/pm.2026.161538}
}
EUVIMED